More breast cancer patients prefer BRCA-mutation testing without prior face-to-face genetic counseling

Long-term follow-up of Jewish women with a BRCA1 and BRCA2 mutation who underwent population genetic screening

(2012) Kelly A. Metcalfe et al.   BREAST CANCER RESEARCH AND TREATMENT

The use of telephone in genetic counseling versus in-person counseling: a randomized study on counselees’ outcome

(2012) Ulla Platten et al.   Familial Cancer

Focusing on Patient Needs and Preferences May Improve Genetic Counseling for Colorectal Cancer

(2012) Simone Salemink et al.   Journal of Genetic Counseling

DNA-testing for BRCA1/2 prior to genetic counselling in patients with breast cancer: design of an intervention study, DNA-direct

(2012) Aisha S Sie et al.   BMC Womens Health

The introduction of a choice to learn pre-symptomatic DNA test results for BRCA or Lynch syndrome either face-to-face or by letter

(2011) JS Voorwinden et al.   CLINICAL GENETICS

Sources of Uncertainty About Daughters’ Breast Cancer Risk that Emerge During Genetic Counseling Consultations

(2011) Carma L. Bylund et al.   Journal of Genetic Counseling

Shortened time interval between colorectal cancer diagnosis and risk testing for hereditary colorectal cancer is not related to higher psychological distress

(2010) K. M. Landsbergen et al.   Familial Cancer

The role of BRCA mutation testing in determining breast cancer therapy

(2010) Alison H. Trainer et al.   Nature Reviews Clinical Oncology

Electronic reminders for pathologists promote recognition of patients at risk for Lynch syndrome: cluster-randomised controlled trial

(2010) L. I. Overbeek et al.   VIRCHOWS ARCHIV

Disparities in BRCA testing: when insurance coverage is not a barrier

(2009) Windy Olaya et al.   AMERICAN JOURNAL OF SURGERY

BRCA testing of breast cancer patients: medical specialists' referral patterns, knowledge and attitudes to genetic testing

(2009) E. VAN RIEL et al.   EUROPEAN JOURNAL OF CANCER CARE

Survival Analysis of Cancer Risk Reduction Strategies forBRCA1/2Mutation Carriers

(2009) Allison W. Kurian et al.   JOURNAL OF CLINICAL ONCOLOGY

Time to stop ovarian cancer screening in BRCA1/2 mutation carriers?

(2008) Nienke M. van der Velde et al.   INTERNATIONAL JOURNAL OF CANCER